Study Start-Up

From the very beginning, you have opportunities to set up your study for success. Let us help you accelerate and optimize your study’s start-up.
Contact us

Position your study start-up for success

A successful study start-up relies on a host of critical factors. According to Tufts Center for Drug Development, 80 percent of delayed trials are often related to patient recruitment, and 48% of sites miss their targets. These realities are forcing biopharmaceutical firms to re-examine how they execute study start-up.

IQVIA can help you get your study off to a fast start.

  • Data driven. Our holistic, data-driven solution integrates technology, insights and proven processes to reduce timelines and position your clinical trial for success.
  • Unify your processes. IQVIA incorporates protocol validation, feasibility and planning, site selection and contracting, regulatory/ethics submissions, document management, and patient recruitment as a fully integrated process, facilitating enrollment – 87% of participating trials have achieved on-time enrollment
  • Optimize and accelerate. Our framework of tools, processes and expertise can get your clinical trial up and running quickly – up to 30% faster than industry benchmark in certain therapeutic areas.

From the very beginning, you have opportunities to set up your study for success. Start-up delays and late completions don’t have to be part of your clinical development story.

Let us help you accelerate and optimize your study’s start-up.

Related Solutions
Site Relationships and Network

A premier network of high-performing clinical trial sites

Partner Sites

Proven clinical research networks to accelerate drug development

Patient Recruitment

Precise, predictable, and efficient clinical trial recruitment

Patient Retention

Recruit and retain the right patients – faster

Research Capability Support and Enhancement

Targeted solutions to support your research